Skip to content

Effect of cipropofol on perioperative cerebrovascular autoregulation in children with congenital heart disease

Effect of cipropofol on perioperative cerebrovascular autoregulation in children with congenital heart disease

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071135
Enrollment
Unknown
Registered
2023-05-05
Start date
2023-05-10
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease

Interventions

Group Etomidate:Etomidate

Sponsors

Shanghai Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Age 0-18 years old, regardless of gender; children who need elective congenital heart disease correction because of congenital heart disease; American College of Anesthesiologists (American Society of Anesthesiologists,ASA) grade 2-4; I or his guardian voluntarily signed an informed consent form.

Exclusion criteria

Exclusion criteria: Emergency operation; history of allergy to experimental drugs; ASA grade > 4; use of mechanical ventilation before operation; use of vasoactive drugs within 24 hours; previous neurosystemic diseases; children and their guardians refused to participate in the study.

Design outcomes

Primary

MeasureTime frame
cerebral blood;

Secondary

MeasureTime frame
cerebral oxygen saturation;Usage of cardiotonic drugs;

Countries

China

Contacts

Public ContactSun Liping

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

suntangmama@163.com+86 13501636482

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026